Prime Medicine Inc (NASDAQ: PRME) is -18.67% lower on its value in year-to-date trading and has touched a low of $1.11 and a high of $5.95 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PRME stock was last observed hovering at around $4.57 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $4.53, the stock is 23.98% and 95.38% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.54 million and changing -0.88% at the moment leaves the stock 70.81% off its SMA200. PRME registered 55.14% gain for a year compared to 6-month loss of 56.75%. The firm has a 50-day simple moving average (SMA 50) of $2.3185 and a 200-day simple moving average (SMA200) of $2.652125.
The stock witnessed a 118.84% gain in the last 1 month and extending the period to 3 months gives it a 225.90%, and is 5.59% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.35% over the week and 15.16% over the month.
Prime Medicine Inc (PRME) has around 214 employees, a market worth around $609.27M and $3.85M in sales. Profit margin for the company is -5252.50%. Distance from 52-week low is 308.11% and -23.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-91.32%).
The EPS is expected to grow by 23.78% this year.
Prime Medicine Inc (PRME) Top Institutional Holders
159.0 institutions hold shares in Prime Medicine Inc (PRME), with institutional investors hold 72.74% of the company’s shares. The shares outstanding are 131.16M, and float is at 52.90M with Short Float at 38.08%. Institutions hold 55.54% of the Float.
The top institutional shareholder in the company is ALPHABET INC. with over 15.06 million shares valued at $77.42 million. The investor’s holdings represent 12.6375% of the PRME Shares outstanding. As of 2024-06-30, the second largest holder is ARK INVESTMENT MANAGEMENT LLC with 6.13 million shares valued at $31.49 million to account for 5.1404 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 6.08 million shares representing 5.1002% and valued at over $31.25 million, while BLACKROCK INC. holds 4.2877 of the shares totaling 5.11 million with a market value of $26.27 million.
Prime Medicine Inc (PRME) Insider Activity
The most recent transaction is an insider purchase by Liu David R., the company’s 10% Owner. SEC filings show that Liu David R. bought 21,000 shares of the company’s common stock on Jun 30 ’25 at a price of $2.52 per share for a total of $52830.0. Following the purchase, the insider now owns 20.24 million shares.
Prime Medicine Inc disclosed in a document filed with the SEC on Jun 23 ’25 that Liu David R. (10% Owner) bought a total of 21,000 shares of the company’s common stock. The trade occurred on Jun 23 ’25 and was made at $2.16 per share for $45402.0. Following the transaction, the insider now directly holds 20.22 million shares of the PRME stock.
Still, SEC filings show that on Jun 16 ’25, Liu David R. (10% Owner) acquired 21,000 shares at an average price of $1.49 for $31196.0. The insider now directly holds 20,198,945 shares of Prime Medicine Inc (PRME).
